The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
For better or for worse: the role of Pim oncogenes in tumorigenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nasser, M. W., Datta, J., Nuovo, G., Kutay, H., Motiwala, T., Majumder, S., Wang, B., Suster, S., Jacob, S. T., & Ghoshal, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804788200 · Cited by 360
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
c-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
Ca 2+ -Induced Apoptosis Through Calcineurin Dephosphorylation of BAD
Wang, H.-G., Pathan, N., Ethell, I. M., Krajewski, S., Yamaguchi, Y., Shibasaki, F., McKeon, F., Bobo, T., Franke, T. F., & Reed, J. C. (1999) · Science · doi:10.1126/science.284.5412.339 · Cited by 1,132
Davis, R. E., Brown, K. D., Siebenlist, U., & Staudt, L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1861 · Cited by 1,051
Wright, G., Tan, B., Rosenwald, A., Hurt, E. H., Wiestner, A., & Staudt, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732008100 · Cited by 1,040
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R. S. K., Küppers, R., & Dalla-Favera, R. (2001) · Nature · doi:10.1038/35085588 · Cited by 1,032
Genomic targets of the human c-Myc protein
Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., & Amati, B. (2003) · Genes & Development · doi:10.1101/gad.1067003 · Cited by 973
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
Molecular Diagnosis of Burkitt's Lymphoma
Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E.-J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055759 · Cited by 897
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
Ellwood-Yen, K., Graeber, T. G., Wongvipat, J., Iruela-Arispe, M. L., Zhang, J., Matusik, R., Thomas, G. V., & Sawyers, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00197-1 · Cited by 816
eIF-4E expression and its role in malignancies and metastases
De Benedetti, A., & Graff, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207545 · Cited by 728
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis
Danial, N. N., Gramm, C. F., Scorrano, L., Zhang, C.-Y., Krauss, S., Ranger, A. M., Robert Datta, S., Greenberg, M. E., Licklider, L. J., Lowell, B. B., et al. (2003) · Nature · doi:10.1038/nature01825 · Cited by 705
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · cited 1×
“, and MYC-driven transformation is characterized by glutamine addictio”
BackgroundControl of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation
Hargreaves, D. C., Horng, T., & Medzhitov, R. (2009) · Cell · doi:10.1016/j.cell.2009.05.047 · Cited by 644
Theo Cuypers, H., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., & Berns, A. (1984) · Cell · doi:10.1016/0092-8674(84)90309-x · Cited by 639
Self-citationDefining mechanisms that regulate RNA polymerase II transcription in vivo
Fuda, N. J., Ardehali, M. B., & Lis, J. T. (2009) · Nature · doi:10.1038/nature08449 · Cited by 576
Eiring, A. M., Harb, J. G., Neviani, P., Garton, C., Oaks, J. J., Spizzo, R., Liu, S., Schwind, S., Santhanam, R., Hickey, C. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.007 · Cited by 560
van Lohuizen, M., Verbeek, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T., & Berns, A. (1989) · Cell · doi:10.1016/0092-8674(89)90589-8 · Cited by 496
Self-citationElvidge, G. P., Glenny, L., Appelhoff, R. J., Ratcliffe, P. J., Ragoussis, J., & Gleadle, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511408200 · Cited by 464
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Hemann, M. T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J. A., Cordon-Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452
Hsieh, A. C., Costa, M., Zollo, O., Davis, C., Feldman, M. E., Testa, J. R., Meyuhas, O., Shokat, K. M., & Ruggero, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.021 · Cited by 434
Synergistic Roles for Pim-1 and c-Myc in STAT3-Mediated Cell Cycle Progression and Antiapoptosis
Shirogane, T., Fukada, T., Muller, J. M. M., Shima, D. T., Hibi, M., & Hirano, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80145-4 · Cited by 426
Zippo, A., Serafini, R., Rocchigiani, M., Pennacchini, S., Krepelova, A., & Oliviero, S. (2009) · Cell · doi:10.1016/j.cell.2009.07.031 · Cited by 411
The survival kinases Akt and Pim as potential pharmacological targets
Amaravadi, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26273 · Cited by 408
Classification of lymphoid neoplasms: the microscope as a tool for disease discovery
Jaffe, E. S., Harris, N. L., Stein, H., & Isaacson, P. G. (2008) · Blood · doi:10.1182/blood-2008-07-077982 · Cited by 382
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
Mikkers, H., Allen, J., Knipscheer, P., Romeyn, L., Hart, A., Vink, E., & Berns, A. (2002) · Nature Genetics · doi:10.1038/ng950 · Cited by 377
Self-citationBrault, L., Gasser, C., Bracher, F., Huber, K., Knapp, S., & Schwaller, J. (2010) · Haematologica · doi:10.3324/haematol.2009.017079 · Cited by 368
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor
Fox, C. J., Hammerman, P. S., Cinalli, R. M., Master, S. R., Chodosh, L. A., & Thompson, C. B. (2003) · Genes & Development · doi:10.1101/gad.1105003 · Cited by 336
Bordeleau, M.-E., Robert, F., Gerard, B., Lindqvist, L., Chen, S. M. H., Wendel, H.-G., Brem, B., Greger, H., Lowe, S. W., Porco, J. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34753 · Cited by 332
Aho, T. L. T., Sandholm, J., Peltola, K. J., Mankonen, H. P., Lilly, M., & Koskinen, P. J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.050 · Cited by 325
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
Choudhary, C., Olsen, J. V., Brandts, C., Cox, J., Reddy, P. N. G., Böhmer, F. D., Gerke, V., Schmidt-Arras, D.-E., Berdel, W. E., Müller-Tidow, C., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.019 · Cited by 321
Mikkers, H., Nawijn, M., Allen, J., Brouwers, C., Verhoeven, E., Jonkers, J., & Berns, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.6104-6115.2004 · Cited by 318
Self-citationDual role of proapoptotic BAD in insulin secretion and beta cell survival
Danial, N. N., Walensky, L. D., Zhang, C.-Y., Choi, C. S., Fisher, J. K., Molina, A. J. A., Datta, S. R., Pitter, K. L., Bird, G. H., Wikstrom, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1717 · Cited by 307
Saris, C. J., Domen, J., & Berns, A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07994.x · Cited by 298
Self-citationeIF4E is a central node of an RNA regulon that governs cellular proliferation
Culjkovic, B., Topisirovic, I., Skrabanek, L., Ruiz-Gutierrez, M., & Borden, K. L. B. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200607020 · Cited by 293
Morishita, D., Katayama, R., Sekimizu, K., Tsuruo, T., & Fujita, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0634 · Cited by 292
Structural Basis of Constitutive Activity and a Unique Nucleotide Binding Mode of Human Pim-1 Kinase
Qian, K. C., Wang, L., Hickey, E. R., Studts, J., Barringer, K., Peng, C., Kronkaitis, A., Li, J., White, A., Mische, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409123200 · Cited by 292
mTORC1 promotes survival through translational control of Mcl-1
Mills, J. R., Hippo, Y., Robert, F., Chen, S. M. H., Malina, A., Lin, C.-J., Trojahn, U., Wendel, H.-G., Charest, A., Bronson, R. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804821105 · Cited by 285
Matikainen, S., Sareneva, T., Ronni, T., Lehtonen, A., Koskinen, P. J., & Julkunen, I. (1999) · Blood · doi:10.1182/blood.v93.6.1980.406k20_1980_1991 · Cited by 278
Zippo, A., De Robertis, A., Serafini, R., & Oliviero, S. (2007) · Nature Cell Biology · doi:10.1038/ncb1618 · Cited by 273
Rhodes, D. R., Sanda, M. G., Otte, A. P., Chinnaiyan, A. M., & Rubin, M. A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.661 · Cited by 271
Pim kinase-dependent inhibition of c-Myc degradation
Zhang, Y., Wang, Z., Li, X., & Magnuson, N. S. (2008) · Oncogene · doi:10.1038/onc.2008.123 · Cited by 265
The PIM-2 Kinase Phosphorylates BAD on Serine 112 and Reverses BAD-induced Cell Death
Yan, B., Zemskova, M., Holder, S., Chin, V., Kraft, A., Koskinen, P. J., & Lilly, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307933200 · Cited by 261
BAD: undertaker by night, candyman by day
Danial, N. N. (2008) · Oncogene · doi:10.1038/onc.2009.44 · Cited by 252
Macdonald, A., Campbell, D. G., Toth, R., McLauchlan, H., Hastie, C. J., & Arthur, J. S. C. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-1 · Cited by 246
Physical and Functional Interactions between Pim-1 Kinase and Cdc25A Phosphatase
Mochizuki, T., Kitanaka, C., Noguchi, K., Muramatsu, T., Asai, A., & Kuchino, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18659 · Cited by 244
Pim-1 regulates cardiomyocyte survival downstream of Akt
Muraski, J. A., Rota, M., Misao, Y., Fransioli, J., Cottage, C., Gude, N., Esposito, G., Delucchi, F., Arcarese, M., Alvarez, R., et al. (2007) · Nature Medicine · doi:10.1038/nm1671 · Cited by 239
Self-citationRuthenium Half‐Sandwich Complexes Bound to Protein Kinase Pim‐1
Debreczeni, J. É., Bullock, A. N., Atilla, G. E., Williams, D. S., Bregman, H., Knapp, S., & Meggers, E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503468 · Cited by 234
Selten, G., Cuypers, H. T., Zijlstra, M., Melief, C., & Berns, A. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02281.x · Cited by 231
Self-citationAmson, R., Sigaux, F., Przedborski, S., Flandrin, G., Givol, D., & Telerman, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8857 · Cited by 231
Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells
Chen, L. S., Redkar, S., Bearss, D., Wierda, W. G., & Gandhi, V. (2009) · Blood · doi:10.1182/blood-2009-03-212852 · Cited by 208
Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival
Hammerman, P. S., Fox, C. J., Birnbaum, M. J., & Thompson, C. B. (2005) · Blood · doi:10.1182/blood-2004-09-3706 · Cited by 205
Fischer, K. M., Cottage, C. T., Wu, W., Din, S., Gude, N. A., Avitabile, D., Quijada, P., Collins, B. L., Fransioli, J., & Sussman, M. A. (2009) · Circulation · doi:10.1161/circulationaha.109.884403 · Cited by 203
Structure and Substrate Specificity of the Pim-1 Kinase
Bullock, A. N., Debreczeni, J., Amos, A. L., Knapp, S., & Turk, B. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510711200 · Cited by 199
Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas.
Selten, G., Cuypers, H. T., & Berns, A. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03852.x · Cited by 198
Self-citationPhosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase
Wang, Z., Bhattacharya, N., Mixter, P. F., Wei, W., Sedivy, J., & Magnuson, N. S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00347-6 · Cited by 197
Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
Xia, Z., Knaak, C., Ma, J., Beharry, Z. M., McInnes, C., Wang, W., Kraft, A. S., & Smith, C. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800937p · Cited by 194
Multiple signaling pathways promote B lymphocyte stimulator–dependent B-cell growth and survival
Woodland, R. T., Fox, C. J., Schmidt, M. R., Hammerman, P. S., Opferman, J. T., Korsmeyer, S. J., Hilbert, D. M., & Thompson, C. B. (2008) · Blood · doi:10.1182/blood-2007-03-077222 · Cited by 193
Pim-1 Ligand-bound Structures Reveal the Mechanism of Serine/Threonine Kinase Inhibition by LY294002
Jacobs, M. D., Black, J., Futer, O., Swenson, L., Hare, B., Fleming, M., & Saxena, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413155200 · Cited by 192
The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases
Selten, G., Cuypers, H. T., Boelens, W., Robanus-Maandag, E., Verbeek, J., Domen, J., van Beveren, C., & Berns, A. (1986) · Cell · doi:10.1016/0092-8674(86)90886-x · Cited by 191
Self-citationPim serine/threonine kinases regulate the stability of Socs-1 protein
Chen, X. P., Losman, J. A., Cowan, S., Donahue, E., Fay, S., Vuong, B. Q., Nawijn, M. C., Capece, D., Cohan, V. L., & Rothman, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042035699 · Cited by 191
Self-citationTamburini, J., Green, A. S., Bardet, V., Chapuis, N., Park, S., Willems, L., Uzunov, M., Ifrah, N., Dreyfus, F., Lacombe, C., et al. (2009) · Blood · doi:10.1182/blood-2008-10-184515 · Cited by 190
Pogacic, V., Bullock, A. N., Fedorov, O., Filippakopoulos, P., Gasser, C., Biondi, A., Meyer-Monard, S., Knapp, S., & Schwaller, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0320 · Cited by 189
van der Lugt, N. M., Domen, J., Verhoeven, E., Linders, K., van der Gulden, H., Allen, J., & Berns, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07251.x · Cited by 187
Self-citationThe Pim kinases control rapamycin-resistant T cell survival and activation
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042020 · Cited by 185
Adipocytes Impair Leukemia Treatment in Mice
Behan, J. W., Yun, J. P., Proektor, M. P., Ehsanipour, E. A., Arutyunyan, A., Moses, A. S., Avramis, V. I., Louie, S. G., Butturini, A., Heisterkamp, N., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0800 · Cited by 183
Lilly, M., Sandholm, J., Cooper, J. J., Koskinen, P. J., & Kraft, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202741 · Cited by 172
Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally.
Verbeek, S., van Lohuizen, M., van der Valk, M., Domen, J., Kraal, G., & Berns, A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.2.1176 · Cited by 169
Self-citationPrimary mediastinal large B-cell lymphoma
Martelli, M., Ferreri, A., Di Rocco, A., Ansuinelli, M., & Johnson, P. W. M. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.01.009 · Cited by 163
Grundler, R., Brault, L., Gasser, C., Bullock, A. N., Dechow, T. N., Woetzel, S., Pogačić, V., Villa, A., Ehret, S., Berridge, G., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082074 · Cited by 162
Li, Y.-Y., Popivanova, B. K., Nagai, Y., Ishikura, H., Fujii, C., & Mukaida, N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4272 · Cited by 161
Kumar, A., Mandiyan, V., Suzuki, Y., Zhang, C., Rice, J., Tsai, J., Artis, D. R., Ibrahim, P., & Bremer, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.02.039 · Cited by 159
Winter, S., Simboeck, E., Fischle, W., Zupkovitz, G., Dohnal, I., Mechtler, K., Ammerer, G., & Seiser, C. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601954 · Cited by 158
Bullock, A. N., Debreczeni, J. E., Fedorov, O., Nelson, A. S., Marsden, B. D., & Knapp, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0504858 · Cited by 157
Novel NEMO/IκB Kinase and NF-κB Target Genes at the Pre-B to Immature B Cell Transition
Li, J., Peet, G. W., Balzarano, D., Li, X., Massa, P. T., Barton, R. W., & Marcu, K. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100846200 · Cited by 156
Chiang, C.-W., Kanies, C. L., Kim, K. W., Fang, W. B., Parkhurst, C., Xie, M., Henry, T. J., & Yang, E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6350-6362.2003 · Cited by 155
Chiang, C.-W., Harris, G., Ellig, C. L., Masters, S. C., Subramanian, R. R., Shenolikar, S., Wadzinski, B. E., & Yang, E. (2001) · Blood · doi:10.1182/blood.v97.5.1289 · Cited by 154
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
Wang, J., Kim, J., Roh, M., Franco, O. E., Hayward, S. W., Wills, M. L., & Abdulkadir, S. A. (2010) · Oncogene · doi:10.1038/onc.2010.10 · Cited by 149
Bachmann, M., Hennemann, H., Xing, P., Hoffmann, I., & Möröy, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404440200 · Cited by 147
Mumenthaler, S. M., Ng, P. Y. B., Hodge, A., Bearss, D. J., Berk, G., Kanekal, S., Redkar, S., Taverna, P., Agus, D. B., & Jain, A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0293 · Cited by 145
PIM1 Protein Kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells
Zhang, F., Beharry, Z. M., Harris, T. E., Lilly, M. B., Smith, C. D., Mahajan, S., & Kraft, A. S. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.9.8210 · Cited by 143
Bachmann, M., Kosan, C., Xing, P., Montenarh, M., Hoffmann, I., & Möröy, T. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.10.010 · Cited by 141
Overexpression of Pim-1 during progression of prostatic adenocarcinoma
Cibull, T. L., Jones, T. D., Li, L., Eble, J. N., Baldridge, L. A., Malott, S. R., Luo, Y., & Cheng, L. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.027672 · Cited by 137
Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3
Peltola, K. J., Paukku, K., Aho, T. L. T., Ruuska, M., Silvennoinen, O., & Koskinen, P. J. (2004) · Blood · doi:10.1182/blood-2003-09-3126 · Cited by 135
Lin, Y.-W., Beharry, Z. M., Hill, E. G., Song, J. H., Wang, W., Xia, Z., Zhang, Z., Aplan, P. D., Aster, J. C., Smith, C. D., et al. (2009) · Blood · doi:10.1182/blood-2009-07-233445 · Cited by 135
Miura, O., Miura, Y., Nakamura, N., Quelle, F. W., Witthuhn, B., Ihle, J. N., & Aoki, N. (1994) · Blood · doi:10.1182/blood.v84.12.4135.bloodjournal84124135 · Cited by 131
Pim‐1 expression in prostatic intraepithelial neoplasia and human prostate cancer
Valdman, A., Fang, X., Pang, S., Ekman, P., & Egevad, L. (2004) · The Prostate · doi:10.1002/pros.20064 · Cited by 131
Zemskova, M., Sahakian, E., Bashkirova, S., & Lilly, M. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709479200 · Cited by 129
Poised Polymerases: On Your Mark…Get Set…Go!
Price, D. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.001 · Cited by 128
High-throughput insertional mutagenesis screens in mice to identify oncogenic networks
Kool, J., & Berns, A. J. M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2647 · Cited by 128
Self-citationZhang, Y., Wang, Z., & Magnuson, N. S. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0388 · Cited by 127
Xie, Y., Xu, K., Dai, B.-T., Guo, Z., Jiang, T., Chen, H., & Qiu, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1209058 · Cited by 126
c-Myc mediates pre-TCR-induced proliferation but not developmental progression
Dose, M., Khan, I., Guo, Z., Kovalovsky, D., Krueger, A., von Boehmer, H., Khazaie, K., & Gounari, F. (2006) · Blood · doi:10.1182/blood-2006-02-005900 · Cited by 124
PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis
Gu, J. J., Wang, Z., Reeves, R., & Magnuson, N. S. (2009) · Oncogene · doi:10.1038/onc.2009.276 · Cited by 121
Gene Expression Profile Predicts Patient Survival of Gastric Cancer After Surgical Resection
Chen, C., Lin, J.-J., Chen, J. J. W., Lee, P., Yang, C., Kuo, M., Chang, K., & Hsieh, F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.2253 · Cited by 121
CD40 Signaling in B Cells Regulates the Expression of the Pim-1 Kinase Via the NF-κB Pathway
Zhu, N., Ramirez, L. M., Lee, R. L., Magnuson, N. S., Bishop, G. A., & Gold, M. R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.744 · Cited by 119
Hsi, E. D., Jung, S., Lai, R. L., Johnson, J. L., Cook, J. R., Jones, D. M., deVos, S., Cheson, B. D., Damon, L. E., & SAID, J. W. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802419640 · Cited by 119
Cohen, A., Grinblat, B., Bessler, H., Kristt, D., Kremer, A., Shalom, S., Schwartz, A., Halperin, M., Merkel, D., & Don, J. (2004) · Leukemia and Lymphoma · doi:10.1080/10428190310001641251 · Cited by 119
Popivanova, B. K., Li, Y., Zheng, H., Omura, K., Fujii, C., Tsuneyama, K., & Mukaida, N. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00390.x · Cited by 116
Pim-1 Kinase Stability Is Regulated by Heat Shock Proteins and the Ubiquitin-Proteasome Pathway
Shay, K. P., Wang, Z., Xing, P., McKenzie, I. F. C., & Magnuson, N. S. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0192 · Cited by 116
Zippo, A., Robertis, A. D., Bardelli, M., Galvagni, F., & Oliviero, S. (2004) · Blood · doi:10.1182/blood-2003-11-3827 · Cited by 115
The great MYC escape in tumorigenesis
Dang, C. V., O’Donnell, K. A., & Juopperi, T. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.005 · Cited by 111
Djouder, N., Metzler, S. C., Schmidt, A., Wirbelauer, C., Gstaiger, M., Aebersold, R. H., Heß, D., & Krek, W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.010 · Cited by 107
Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma
Reiser–Erkan, C., Erkan, M., Zheng, P., Békási, S., Giese, N. A., Streit, S., Michalski, C. W., Friess, H., & Kleeff, J. H. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.9.6418 · Cited by 102
Beharry, Z. M., Zemskova, M., Mahajan, S., Zhang, F., Ma, J., Xia, Z., Lilly, M. B., Smith, C. D., & Kraft, A. S. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1037 · Cited by 102
Pim-1 plays a pivotal role in hypoxia-induced chemoresistance
Chen, J., Kobayashi, M., Darmanin, S., Qiao, Y., Gully, C., Zhao, R., Yeung, S. J., & Lee, M. (2009) · Oncogene · doi:10.1038/onc.2009.124 · Cited by 99
Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation
Chen, J., Kobayashi, M., Darmanin, S., 高橋, 義., Gully, C., Zhao, R., Kondo, S., Wang, H., Wang, H., Yeung, S. J., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080972 · Cited by 98
KID-1, a Protein Kinase Induced by Depolarization in Brain
Feldman, J. D., Vician, L. J., Crispino, M., Tocco, G., Marcheselli, V. L., Bazan, N. G., Baudry, M., & Herschman, H. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16535 · Cited by 98
Zhao, Y., Hamza, M. S., Leong, H. S., Lim, C.-B., Pan, Y.-F., Cheung, E. C. W., Soo, K.-C., & Iyer, N. G. (2007) · Oncogene · doi:10.1038/sj.onc.1210625 · Cited by 96
Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB Activation
Hammerman, P. S., Fox, C. J., Cinalli, R. M., Xu, A., Wagner, J. D. O., Lindsten, T., & Thompson, C. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2284 · Cited by 95
Peperzak, V., Veraar, E. A. M., Keller, A. M., Xiao, Y., & Borst, J. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000159 · Cited by 93
Maximal STAT5-Induced Proliferation and Self-Renewal at Intermediate STAT5 Activity Levels
Wierenga, A. T. J., Vellenga, E., & Schuringa, J. J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01025-08 · Cited by 92
Altering chemosensitivity by modulating translation elongation
Robert, F., Carrier, M., Rawe, S., Chen, S., Lowe, S., & Pelletier, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005428 · Cited by 90
Mizuno, K., Shirogane, T., Shinohara, A., Iwamatsu, A., Hibi, M., & Hirano, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4405 · Cited by 89
Recombinant human pim-1 protein exhibits serine/threonine kinase activity
Hoover, D. S., Friedmann, M., Reeves, R., & Magnuson, N. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92804-8 · Cited by 87
Cardiac Progenitor Cell Cycling Stimulated by Pim-1 Kinase
Cottage, C. T., Bailey, B., Fischer, K. M., Avitabile, D., Collins, B. L., Tuck, S., Quijada, P. J., Gude, N. A., Alvarez, R., Muraski, J. A., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.208629 · Cited by 87
Hoover, D. S., Wingett, D. G., Zhang, J., Reeves, R., & Magnuson, N. S. (1997) · PubMed · Cited by 87
Liso, A. (2006) · Blood · doi:10.1182/blood-2005-10-3949 · Cited by 84
Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells
Domen, J., van der Lugt, N. M. T., Laird, P. W., Saris, C. P., Clarke, A. R., Hooper, M. L., & Berns, A. J. M. (1993) · Blood · doi:10.1182/blood.v82.5.1445.1445 · Cited by 84
Self-citationEvidence implicating Gfi‐1 and Pim‐1 in pre‐T‐cell differentiation steps associated with β‐selection
Schmidt, T., Karsunky, H., Rödel, B., Zevnik, B., Elsässer, H., & Möröy, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5349 · Cited by 83
Konietzko, U., Kauselmann, G., Scafidi, J., Staubli, U., Mikkers, H., Berns, A. J. M., Schweizer, M., Waltereit, R., & Kuhl, D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.12.3359 · Cited by 80
Self-citationPim Kinase Substrate Identification and Specificity
Peng, C., Knebel, A., Morrice, N. A., Li, X., Barringer, K., Li, J., Jakes, S., WERNEBURG, B. G., & Wang, L. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvm040 · Cited by 77
Kim, O., Jiang, T., Xie, Y., Guo, Z., Chen, H., & Qiu, Y. (2004) · Oncogene · doi:10.1038/sj.onc.1207304 · Cited by 77
Negative regulation of Pim-1 protein kinase levels by the B56β subunit of PP2A
Ma, J., Arnold, H., Lilly, M. B., Sears, R. C., & Kraft, A. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210323 · Cited by 77
Deutsch, A. J. A., Aigelsreiter, A., Staber, P. B., Beham, A., Linkesch, W., Guelly, C., Brezinschek, R. I., Frühwirth, M., Emberger, W., Buettner, M. J., et al. (2006) · Blood · doi:10.1182/blood-2006-06-030494 · Cited by 77
Protein Phosphatase 2A Regulates the Stability of Pim Protein Kinases
Losman, J. A., Chen, X. P., Vuong, B. Q., Fay, S., & Rothman, P. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208246200 · Cited by 76
Pim kinase inhibitors: a survey of the patent literature
Morwick, T. M. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903496442 · Cited by 76
Peltola, K. J., Hollmén, M., Maula, S., Rainio, E.-M., Ristamäki, R., Luukkaa, M., Sandholm, J. A., Sundvall, M., Elenius, K., Koskinen, P. J., et al. (2009) · Neoplasia · doi:10.1593/neo.81038 · Cited by 75
Aksoy, I., Sakabedoyan, C., Bourillot, P.-Y., Malashicheva, A., Mancip, J., Knoblauch, K., Afanassieff, M., & Savatier, P. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0066 · Cited by 75
Zheng, H., Tsuneyama, K., Takahashi, H., Miwa, S., Sugiyama, T., Popivanova, B. K., Fujii, C., Nomoto, K., Mukaida, N., & Takano, Y. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0310-1 · Cited by 74
Pim-1 levels determine the size of early B lymphoid compartments in bone marrow.
Domen, J., van der Lugt, N. M., Acton, D., et al. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1665 · Cited by 73
Pim-1 Phosphorylates the DNA Binding Domain of c-Myb
Winn, L. M., Lei, W., & Ness, S. A. (2003) · Cell Cycle · doi:10.4161/cc.2.3.383 · Cited by 72
Dai, H., Li, R., Wheeler, T., de Vivar, A. D., Frolov, A., Tahir, S., Agoulnik, I., Thompson, T., Rowley, D., & Ayala, G. (2005) · The Prostate · doi:10.1002/pros.20294 · Cited by 69
Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity
Aho, T. L. T., Sandholm, J. A., Peltola, K. J., Ito, Y., & Koskinen, P. J. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-21 · Cited by 68
Primary mediastinal large B-cell lymphoma
Martelli, M., Ferreri, A. J. M., & Johnson, P. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.07.020 · Cited by 68
Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer.
Warnecke‐Eberz, U., Bollschweiler, E., Drebber, U., Metzger, R., Baldus, S. E., Hölscher, A. H., & Mönig, S. (2009) · PubMed · Cited by 67
Role of Pim-1 in Smooth Muscle Cell Proliferation
Katakami, N., Kaneto, H., Hao, H., Umayahara, Y., Fujitani, Y., Sakamoto, K., Gorogawa, S.-I., Yasuda, T., Kawamori, D., Kajimoto, Y., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409140200 · Cited by 65
de Vos, S., Krug, U. O., Hofmann, W., et al. (2003) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200303000-00005 · Cited by 61
Jacobs, H., Krimpenfort, P., Haks, M. C., Allen, J., Blom, B., Démollière, C., Kruisbeek, A. M., Spits, H., & Berns, A. J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1059 · Cited by 60
Self-citationZhu, Y., Hollmén, J., Räty, R., Aalto, Y., Nagy, B., Elonen, E., Kere, J., Mannila, H., Franssila, K., & Knuutila, S. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03931.x · Cited by 59
Domen, J., Von Lindern, M., Hermans, A., et al. (1987) · PubMed · Cited by 58
Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death
Pircher, T. J., Zhao, S., Geiger, J. N., Joneja, B., & Wojchowski, D. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203684 · Cited by 56
Protein Kinase Expression during Murine Mammary Development
Chodosh, L. A., Gardner, H. P., Rajan, J. V., Stairs, D. B., Marquis, S. T., & Leder, P. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9614 · Cited by 55
Wu, Y., Wang, Y. Y., Nakamoto, Y., Li, Y.-Y., Baba, T., Kaneko, S., Fujii, C., & Mukaida, N. (2010) · Oncogene · doi:10.1038/onc.2009.504 · Cited by 50
c‐Myb regulates the proliferation of immature thymocytes following β‐selection
Pearson, R. B., & Weston, K. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6112 · Cited by 50
Microarray‐based classification of diffuse large B‐cell lymphoma
Poulsen, C. B., Borup, R., Nielsen, F. C., Borregaard, N., Hansen, M., Grønbæk, K., Møller, M. B., & Ralfkiaer, E. M. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00429.x · Cited by 48
IL-4 Selectively Inhibits IL-2-Triggered Stat5 Activation, But Not Proliferation, in Human T Cells
Castro, A., Sengupta, T. K., Ruiz, D. C., Yang, E., & Ivashkiv, L. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1261 · Cited by 46
Up-regulation of a serine–threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma
Chiang, W., Yen, C.-Y., Lin, C.-N., Liaw, G.-A., Chiu, C.-T., Hsia, Y.-J., & Liu, S.-Y. (2006) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2006.01.027 · Cited by 43
Essential contribution of Ets‐1 to constitutive Pim‐3 expression in human pancreatic cancer cells
Li, Y., Wu, Y., Tsuneyama, K., Baba, T., & Mukaida, N. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01059.x · Cited by 37
Gong, J.-P., Wang, J.-J., Ren, K., Liu, C.-A., Li, B., & Shi, Y.-J. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.03.033 · Cited by 36
Primary Cutaneous Marginal Zone B-Cell Lymphomas Are Targeted by Aberrant Somatic Hypermutation
Deutsch, A. J. A., Frühwirth, M., Aigelsreiter, A., Cerroni, L., & Neumeister, P. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.243 · Cited by 34
Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma
Halldórsdóttir, A. M., Frühwirth, M., Deutsch, A. J. A., Aigelsreiter, A., Beham‐Schmid, C., Agnarsson, B. A., Neumeister, P., & Burack, R. (2008) · Leukemia Research · doi:10.1016/j.leukres.2007.11.028 · Cited by 32
Pim-1 kinase expression during murine mammary development
Gapter, L. A., Magnuson, N. S., Ng, K., & Hosick, H. L. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.110 · Cited by 31
Pim3 negatively regulates glucose-stimulated insulin secretion
Vlacich, G. R., Nawijn, M. C., Webb, G. C., & Steiner, D. F. (2010) · Islets · doi:10.4161/isl.2.5.13058 · Cited by 22
Self-citationLeduc, I., Karsunky, H., Mathieu, N., Schmidt, T., Verthuy, C., Ferrier, P., & Möröy, T. (2000) · International Immunology · doi:10.1093/intimm/12.10.1389 · Cited by 22
Regulation of RNA Polymerase II Elongation by c-Myc
Price, D. H. (2010) · Cell · doi:10.1016/j.cell.2010.04.016 · Cited by 20
Sivertsen, E. A., Galteland, E., Mu, D., Holte, H., Meza‐Zepeda, L. A., Myklebost, O., Patzke, S., Smeland, E. B., & Stokke, T. (2006) · Leukemia · doi:10.1038/sj.leu.2404094 · Cited by 14
PIM1 and MYC: a changing relationship?
Naud, J., & Eilers, M. (2007) · Nature Cell Biology · doi:10.1038/ncb0807-873 · Cited by 9
(2006) · PubMed
Research works printed but not linked: 9
- Padma, R. & Nagarajan, L. The human PIM-1 gene product is a protein serine kinase. Cancer Res. 51, 2486–2489 (1991).
- Laird, P. W. et al. In vivo analysis of Pim-1 deficiency. Nucleic Acids Res. 21, 4750–4755 (1993). · doi:10.1093/nar/21.20.4750
- Stewart, B. E. & Rice, R. H. Differentiation-associated expression of the proto-oncogene pim-1 in cultured human keratinocytes. J. Invest. Dermatol. 105, 699–703 (1995). · doi:10.1111/1523-1747.ep12324482
- Warnecke-Eberz, U. et al. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases. Oncol. Rep. 20, 619–624 (2008).
- von Lindern, M., van Agthoven, T., Hagemeijer, A., Adriaansen, H. & Grosveld, G. The human pim-1 gene is not directly activated by the translocation (6;9) in acute nonlymphocytic leukemia. Oncogene 4, 75–79 (1989).
- Stewart, M. et al. Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas. Cancer Res. 67, 5126–5133 (2007). · doi:10.1158/0008-5472.can-07-0433
- Xu, Y. et al. Overexpression of PIM-1 is a potential biomarker in prostate carcinoma. J. Surg. Oncol. 92, 326–330 (2005). · doi:10.1002/jso.20325
- Ayala, G. E. et al. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res. 64, 6082–6090 (2004). · doi:10.1158/0008-5472.can-04-0838
- Beier, U. H., Weise, J. B., Laudien, M., Sauerwein, H. & Gorogh, T. Overexpression of Pim-1 in head and neck squamous cell carcinomas. Int. J. Oncol. 30, 1381–1387 (2007).
Cited by
Bioactive Benzofuran derivatives: A review
Khanam, H., & Shamsuzzaman (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.039 · Cited by 554
Indole: A privileged scaffold for the design of anti-cancer agents
Wan, Y., Li, Y., Yan, C., Yan, M., & Tang, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111691 · Cited by 516
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
Dadashpour, S., & Emami, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.065 · Cited by 343
4E-BP1, a multifactor regulated multifunctional protein
Qin, X., Jiang, B., & Zhang, Y. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1151581 · Cited by 337
USP7 small-molecule inhibitors interfere with ubiquitin binding.
Kategaya, L., Di Lello, P., Rougé, L., Pastor, R., Clark, K. R., Drummond, J., Kleinheinz, T., Lin, E., Upton, J.-P., Prakash, S., et al. (2017) · Nature · doi:10.1038/nature24006 · Cited by 333
Metadata
- Authors
- Nawijn, M. C., Alendar, A., & Berns, A.
- Venue
- Nature Reviews Cancer
- Published
- 2010-12-09
- Volume
- 11
- Issue
- 1
- Pages
- 23-34
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2121323579
- Cited by
- 481
- References
- 168
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.